title: Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues.
abstract: OBJECTIVE
  Recent work has demonstrated an important decrease in breast cancers for women with systemic lupus erythematosus (SLE). The reason behind this phenomenon is unknown. Our purpose was to explore whether the single nucleotide polymorphisms (SNPs) predisposing to SLE might be protective against breast cancer (in women in the general population).
  
  
  METHODS
  We focused on loci relevant to 10 SNPs associated with SLE (with a p value of <10(-9)). We determined whether we could establish a decreased frequency of these SNPs in breast cancer cases versus controls, within the general population. To do this we used a large breast cancer genome-wide association study (GWAS) dataset, involving 3,659 breast cancer cases and 4,897 controls. These subjects were all primarily of European ancestry.
  
  
  RESULTS
  The population-based GWAS breast cancer data we examined suggested little evidence for important associations between breast cancer and SLE-related SNPs. Within the general population GWAS data, a cytosine(C) nucleotide substitution at rs9888739 (on chromosome 16p11.2) showed a very weak inverse association with breast cancer. The odds ratio (OR) for the rs9888739-C allele was 0.907551 (p value 0.049899) in the GWAS breast cancer sample, compared to controls. There was a slightly stronger, positive, association with breast cancer for rs6445975-G (Guanine) on chromosome 3p14.3, with a breast cancer OR of 1.0911 (p value 0.0097).
  
  
  CONCLUSIONS
  Within this large breast cancer dataset, we did not demonstrate important associations with 10 lupus-associated SNPs. If decreased breast cancer risk in SLE is influenced by genetic profiles, this may be due to complex interactions and/or epigenetic factors.
authors.affiliation: Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada. sasha.bernatsky@mail.mcgill.ca
authors.forename: S
authors.initials: S
authors.lastname: Bernatsky
authors.forename: D F
authors.initials: DF
authors.lastname: Easton
authors.forename: A
authors.initials: A
authors.lastname: Dunning
authors.forename: K
authors.initials: K
authors.lastname: Michailidou
authors.forename: R
authors.initials: R
authors.lastname: Ramsey-Goldman
authors.forename: C
authors.initials: C
authors.lastname: Gordon
authors.forename: A E
authors.initials: AE
authors.lastname: Clarke
authors.forename: W
authors.initials: W
authors.lastname: Foulkes
mesh_terms: D000483:Alleles; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics*; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D044465:White People / Q000235:genetics